Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.-Reference-Cited by-同舟云学术

Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

Published:1996-07-01 Issue:1 Volume:39 Page:82-86
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Lofberg R,Rutgeerts P,Malchow H,Lamers C,Danielsson A,Olaison G,Jewell D,Ostergaard Thomsen O,Lorenz-Meyer H,Goebell H,Hodgson H,Persson T,Seidegard C

Publisher

BMJ

Subject

Gastroenterology

Reference12 articles.

1. Medical management of Crohn's disease;Meyers, S.; Sachar, D.B.;Hepatogastroenterology,1990

2. National Cooperative Crohn's Disease Study: Results of drug treatment;Summers, R.W.; Switz, D.M.; JT, Jr, Sessions; Becktel, J.M.; Best, W.R.; Kern, F.;Gastroenterology,1979

3. European Cooperative Crohn's Disease Study (ECCDS);Malchow, H.; Ewe, K.; Brandes, J.W.; Goebell, H.; Ehms, H.; Sommer, H.,1984

4. Frequency of glucocorticoid resistence and dependency in Crohn's disease;Munkholm, P.; Langholz, E.; Davidsen, M.; Binder, V.;Gut,1994

5. A comparison of budesonide with prednisolone for active Crohn's disease;Rutgeerts, P.; Lofberg, R.; Malchow, H.; Lamers, C.; Olaison, G.; Jewell, D.;N Engl J Med,1994

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2023-06-23

2. Long-Term Usage of Oral Glucocorticoids Leading to Adrenal Insufficiency: A Comprehensive Review of the Literature;Cureus;2023-05-12

3. 2021 Corticosteroids;Pediatric Inflammatory Bowel Disease;2023

4. Glucocorticoid induced adrenal insufficiency;BMJ;2021-07-12

5. AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease;Gastroenterology;2021-06